MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases

Journal of Experimental Medicine

Volumn 211, Issue 5, 2014, Pages 887-907

  Yu, Minjia ^a,b   Zhou, Hao ^a,c   Zhao, Junjie ^a   Xiao, Nengming ^a   Roychowdhury, Sanjoy ^a   Schmitt, David ^a   Hu, Bingqing ^a   Harding, Clifford V ^e   Hise, Amy G ^e,f   Hazen, Stanley L ^a   DeFranco, Anthony L ^d   Fox, Paul L ^a   Morton, Richard E ^a   Dicorleto, Paul E ^a   Febbraio, Maria ^a   Nagy, Laura E ^a   Smith, Jonathan D ^a   Wang, Jian an ^b   Li, Xiaoxia ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CLEVELAND STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BONE MARROW CELL; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; IN VIVO STUDY; INFLAMMATORY DISEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; OBESITY; OBESITY ASSOCIATED INFLAMMATORY DISEASE; PHENOTYPE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD11B; ENDOTHELIAL CELLS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN; MICE; MYELOID CELLS; MYELOID DIFFERENTIATION FACTOR 88; OBESITY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84899733210     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131314     Document Type: Article

References (125)

1. Abu-Soud, H.M., and S.L. Hazen. 2000a. Nitric oxide is a physiological substrate for mammalian peroxidases. J. Biol. Chem. http://dx.doi.org/10.1074/jbc.275.48.37524 275:37524-37532
2. Abu-Soud, H.M., and S.L. Hazen. 2000b. Nitric oxide modulates the catalytic activity of myeloperoxidase. J. Biol. Chem. http://dx.doi.org/10.1074/jbc.275.8.5425 275:5425-5430
3. Aird, W.C. 2007. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. http://dx.doi.org/10.1161/01.RES.0000255691.76142.4a 100:158-173
4. Alkhouri, N., A. Gornicka, M.P. Berk, S. Thapaliya, L.J. Dixon, S. Kashyap, P.R. Schauer, and A.E. Feldstein. 2010. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J. Biol. Chem. http://dx.doi.org/10.1074/jbc. M109.074252 285:3428-3438
5. Avouac, J., and Y. Allanore. 2008. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Expert Opin. Pharmacother. http://dx.doi.org/10.1517/14656566.9.7.1121 9:1121-1128
6. Baldus, S., C. Heeschen, T. Meinertz, A.M. Zeiher, J.P. Eiserich, T. Münzel, M.L. Simoons, C.W. Hamm, and C. Investigators; CAPTURE Investigators. 2003. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. http://dx.doi.org/10.1161/01.CIR.0000090690.67322.51 108:1440-1445
7. Björkbacka, H., V.V. Kunjathoor, K.J. Moore, S. Koehn, C.M. Ordija, M.A. Lee, T. Means, K. Halmen, A.D. Luster, D.T. Golenbock, and M.W. Freeman. 2004. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. http://dx.doi.org/10.1038/nm1008 10:416-421
8. Boillée, S., K. Yamanaka, C.S. Lobsiger, N.G. Copeland, N.A. Jenkins, G. Kassiotis, G. Kollias, and D.W. Cleveland. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. http://dx.doi.org/10.1126/science.1123511 312:1389-1392
9. Brochériou, I., S. Maouche, H. Durand, V. Braunersreuther, G. Le Naour, A. Gratchev, F. Koskas, F. Mach, J. Kzhyshkowska, and E. Ninio. 2011. Antagonistic regulation of macrophage phenotype by M-CSF and GMCSF: implication in atherosclerosis. Atherosclerosis. http://dx.doi.org/10.1016/j.atherosclerosis.2010.11.023 214:316-324
10. Brown, J., H. Wang, G.N. Hajishengallis, and M. Martin. 2011. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J. Dent. Res. http://dx.doi.org/10.1177/0022034510381264 90:417-427
11. Caligiuri, G., A. Nicoletti, X. Zhou, I. Törnberg, and G.K. Hansson. 1999. Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis. http://dx.doi.org/10.1016/S0021-9150(99)00081-7 145:301-308
12. Cani, P.D., J. Amar, M.A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A.M. Neyrinck, F. Fava, K.M. Tuohy, C. Chabo, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. http://dx.doi.org/10.2337/db06-1491 56:1761-1772
13. Cani, P.D., R. Bibiloni, C. Knauf, A. Waget, A.M. Neyrinck, N.M. Delzenne, and R. Burcelin. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. http://dx.doi.org/10.2337/db07-1403 57:1470-1481
14. Chen, N., L. Liu, Y. Zhang, H.N. Ginsberg, and Y.H. Yu. 2005. Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue. Diabetes. http://dx.doi.org/10.2337/diabetes.54.12.3379 54:3379-3386
15. Cheung, A.T., J. Wang, D. Ree, J.K. Kolls, and M. Bryer-Ash. 2000. Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes. http://dx.doi.org/10.2337/diabetes.49.5.810 49:810-819
16. Chi, H., E. Messas, R.A. Levine, D.T. Graves, and S. Amar. 2004. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation. http://dx.doi.org/10.1161/01.CIR.0000142085.39015.31 110:1678-1685
17. Chinetti-Gbaguidi, G., and B. Staels. 2011. Macrophage polarization in metabolic disorders: functions and regulation. Curr. Opin. Lipidol. http://dx.doi.org/10.1097/MOL.0b013e32834a77b4 22:365-372
18. Chitu, V., and E.R. Stanley. 2006. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. http://dx.doi.org/10.1016/j.coi.2005.11.006 18:39-48
19. Creely, S.J., P.G. McTernan, C.M. Kusminski, M. Fisher, N.F. Da Silva, M. Khanolkar, M. Evans, A.L. Harte, and S. Kumar. 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. http://dx.doi.org/10.1152/ajpendo.00302.2006 292:E740-E747
20. Dasu, M.R., S. Ramirez, and R.R. Isseroff. 2012. Toll-like receptors and diabetes: a therapeutic perspective. Clin. Sci. http://dx.doi.org/10.1042/CS20110357 122:203-214
21. De Taeye, B.M., T. Novitskaya, O.P. McGuinness, L. Gleaves, M. Medda, J.W. Covington, and D.E. Vaughan. 2007. Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. http://dx.doi.org/10.1152/ajpendo.00194.2007 293:E713-E725
22. Dixon, W.G., and D.P. Symmons. 2007. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. Ann. Rheum. Dis. http://dx.doi.org/10.1136/ard.2006.063867 66:1132-1136
23. Ehses, J.A., G. Lacraz, M.H. Giroix, F. Schmidlin, J. Coulaud, N. Kassis, J.C. Irminger, M. Kergoat, B. Portha, F. Homo-Delarche, and M.Y. Donath. 2009. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc. Natl. Acad. Sci. USA. http://dx.doi.org/10.1073/pnas.0810087106 106:13998-14003
24. Elhage, R., A. Maret, M.T. Pieraggi, J.C. Thiers, J.F. Arnal, and F. Bayard. 1998. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation. http://dx.doi.org/10.1161/01.CIR.97.3.242 97:242-244
25. Emanuela, F., M. Grazia, R. Marco, L. Maria Paola, F. Giorgio, and B. Marco. 2012. Inflammation as a Link between Obesity and Metabolic Syndrome. J. Nutr. Metab. http://dx.doi.org/10.1155/2012/476380 2012:476380
26. Erridge, C. 2011. Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. Atherosclerosis. http://dx.doi.org/10.1016/j.atherosclerosis.2011.02.043 216:1-6
27. Febbraio, M., E.A. Podrez, J.D. Smith, D.P. Hajjar, S.L. Hazen, H.F. Hoff, K. Sharma, and R.L. Silverstein. 2000. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. http://dx.doi.org/10.1172/JCI9259 105:1049-1056
28. Febbraio, M., E. Guy, and R.L. Silverstein. 2004. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. http://dx.doi.org/10.1161/01.ATV.0000148007.06370.68 24:2333-2338
29. Fernández-Real, J.M., S. Pérez del Pulgar, E. Luche, J.M. Moreno-Navarrete, A. Waget, M. Serino, E. Sorianello, A. Sánchez-Pla, F.C. Pontaque, J. Vendrell, et al. 2011. CD14 modulates inflammation-driven insulin resistance. Diabetes. http://dx.doi.org/10.2337/db10-1210 60:2179-2186
30. Ferrante, A., A.R. Giardina, F. Ciccia, G. Parrinello, G. Licata, G. Avellone, E. Giardina, R. Impastato, and G. Triolo. 2009. Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. Rheumatol. Int. http://dx.doi.org/10.1007/s00296-009-0935-2 30:193-198
31. Fischer, B., A. Von Knethen, and B. Brüne. 2002. Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-gamma. J. Immunol. 168:2828-2834
32. Fleetwood, A.J., T. Lawrence, J.A. Hamilton, and A.D. Cook. 2007. Granulocytemacrophage colony-stimulating factor (CSF) and macrophage CSFdependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178:5245-5252
33. Fraczek, J., T.W. Kim, H. Xiao, J. Yao, Q. Wen, Y. Li, J.L. Casanova, J. Pryjma, and X. Li. 2008. The kinase activity of IL-1 receptor-associated kinase 4 is required for interleukin-1 receptor/toll-like receptor-induced TAK1-dependent NFkappaB activation. J. Biol. Chem. http://dx.doi.org/10.1074/jbc. M804779200 283:31697-31705
34. Fresno, M., R. Alvarez, and N. Cuesta. 2011. Toll-like receptors, inflammation, metabolism and obesity. Arch. Physiol. Biochem. http://dx.doi.org/10.3109/13813455.2011.562514 117:151-164
35. Fujisaka, S., I. Usui, A. Bukhari, M. Ikutani, T. Oya, Y. Kanatani, K. Tsuneyama, Y. Nagai, K. Takatsu, M. Urakaze, et al. 2009. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes. http://dx.doi.org/10.2337/db08-1475 58:2574-2582
36. Galkina, E., A. Kadl, J. Sanders, D. Varughese, I.J. Sarembock, and K. Ley. 2006. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. http://dx.doi.org/10.1084/jem.20052205 203:1273-1282
37. Gallardo-Soler, A., C. Gómez-Nieto, M.L. Campo, C. Marathe, P. Tontonoz, A. Castrillo, and I. Corraliza. 2008. Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptorgamma/delta-mediated effect that links lipid metabolism and immunity. Mol. Endocrinol. http://dx.doi.org/10.1210/me.2007-0525 22:1394-1402
38. Gay, N.J., M. Gangloff, and L.A. O'Neill. 2011. What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol. http://dx.doi.org/10.1016/j.it.2010.12.005 32:104-109
39. Haghighat, A., D. Weiss, M.K. Whalin, D.P. Cowan, and W.R. Taylor. 2007. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.665570 115:2049-2054
40. Hamilton, J.A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. http://dx.doi.org/10.1038/nri2356 8:533-544
41. Hamilton, J.A., D. Myers, W. Jessup, F. Cochrane, R. Byrne, G. Whitty, and S. Moss. 1999. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. http://dx.doi.org/10.1161/01.ATV.19.1.98 19:98-105
42. Harari, O.A., P. Alcaide, D. Ahl, F.W. Luscinskas, and J.K. Liao. 2006. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway. Circ. Res. http://dx.doi.org/10.1161/01.RES.0000220105.85182.28 98:1134-1140
43. Hatley, M.E., S. Srinivasan, K.B. Reilly, D.T. Bolick, and C.C. Hedrick. 2003. Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice. J. Biol. Chem. 278:25369-25375
44. Hazen, S.L., and J.W. Heinecke. 1997. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. http://dx.doi.org/10.1172/JCI119379 99:2075-2081
45. Hazen, S.L., F.F. Hsu, K. Duffin, and J.W. Heinecke. 1996. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. http://dx.doi.org/10.1074/jbc.271.38.23080 271:23080-23088
46. Hazen, S.L., R. Zhang, Z. Shen, W. Wu, E.A. Podrez, J.C. MacPherson, D. Schmitt, S.N. Mitra, C. Mukhopadhyay, Y. Chen, et al. 1999. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo. Circ. Res. http://dx.doi.org/10.1161/01.RES.85.10.950 85:950-958
47. Himes, R.W., and C.W. Smith. 2010. Tlr2 is critical for diet-induced metabolic syndrome in a murine model. FASEB J. http://dx.doi.org/10.1096/fj.09-141929 24:731-739
48. Hirosumi, J., G. Tuncman, L. Chang, C.Z. Görgün, K.T. Uysal, K. Maeda, M. Karin, and G.S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature. http://dx.doi.org/10.1038/nature01137 420:333-336
49. Holvoet, P., D.H. Lee, M. Steffes, M. Gross, and D.R. Jacobs Jr. 2008. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA. http://dx.doi.org/10.1001/jama.299.19.2287 299:2287-2293
50. Hosoi, T., S. Yokoyama, S. Matsuo, S. Akira, and K. Ozawa. 2010. Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS ONE. http://dx.doi.org/10.1371/journal.pone.0012537 5:5
51. Hotamisligil, G.S. 2006. Inflammation and metabolic disorders. Nature. http://dx.doi.org/10.1038/nature05485 444:860-867
52. Hotamisligil, G.S., N.S. Shargill, and B.M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. http://dx.doi.org/10.1126/science.7678183 259:87-91
53. Hou, B., B. Reizis, and A.L. DeFranco. 2008. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity. http://dx.doi.org/10.1016/j.immuni.2008.05.016 29:272-282
54. Huber, S.A., P. Sakkinen, D. Conze, N. Hardin, and R. Tracy. 1999. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. http://dx.doi.org/10.1161/01.ATV.19.10.2364 19:2364-2367
55. Itabe, H., T. Obama, and R. Kato. 2011. The Dynamics of Oxidized LDL during Atherogenesis. J. Lipids. http://dx.doi.org/10.1155/2011/418313 2011:418313
56. Jager, J., T. Grémeaux, M. Cormont, Y. Le Marchand-Brustel, and J.F. Tanti. 2007. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology. http://dx.doi.org/10.1210/en.2006-0692 148:241-251
57. Kang, Z., C.Z. Altuntas, M.F. Gulen, C. Liu, N. Giltiay, H. Qin, L. Liu, W. Qian, R.M. Ransohoff, C. Bergmann, et al. 2010. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity. http://dx.doi.org/10.1016/j.immuni.2010.03.004 32:414-425
58. Kang, Z., S. Swaidani, W. Yin, C. Wang, J.L. Barlow, M.F. Gulen, K. Bulek, J.S. Do, M. Aronica, A.N. McKenzie, et al. 2012. Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(-)c-Kit(+) innate cell population. Immunity. http://dx.doi.org/10.1016/j.immuni.2012.03.021 36:821-833
59. Kano, A., M.J. Wolfgang, Q. Gao, J. Jacoby, G.X. Chai, W. Hansen, Y. Iwamoto, J.S. Pober, R.A. Flavell, and X.Y. Fu. 2003. Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J. Exp. http://dx.doi.org/10.1084/jem.20030077 Med. 198:1517-1525
60. Karaskov, E., C. Scott, L. Zhang, T. Teodoro, M. Ravazzola, and A. Volchuk. 2006. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology. 147:3398-3407
61. Kenny, E.F., and L.A. O'Neill. 2008. Signalling adaptors used by Toll-like receptors: an update. Cytokine. http://dx.doi.org/10.1016/j.cyto.2008.07.010 43:342-349
62. Kiechl, S., E. Lorenz, M. Reindl, C.J. Wiedermann, F. Oberhollenzer, E. Bonora, J. Willeit, and D.A. Schwartz. 2002. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa012673 347:185-192
63. Kim, T.W., K. Staschke, K. Bulek, J. Yao, K. Peters, K.H. Oh, Y. Vandenburg, H. Xiao, W. Qian, T. Hamilton, et al. 2007. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. http://dx.doi.org/10.1084/jem.20061825 Med. 204:1025-1036
64. Kim, D.H., D. Sandoval, J.A. Reed, E.K. Matter, E.G. Tolod, S.C. Woods, and R.J. Seeley. 2008. The role of GM-CSF in adipose tissue inflammation. Am. J. Physiol. Endocrinol. Metab. http://dx.doi.org/10.1152/ajpendo.00061.2008 295:E1038-E1046
65. Kirii, H., T. Niwa, Y. Yamada, H. Wada, K. Saito, Y. Iwakura, M. Asano, H. Moriwaki, and M. Seishima. 2003. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. http://dx.doi.org/10.1161/01.ATV.0000064374.15232.C3 23:656-660
66. Kleemann, R., S. Zadelaar, and T. Kooistra. 2008. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. http://dx.doi.org/10.1093/cvr/cvn120 79:360-376
67. Klover, P.J., T.A. Zimmers, L.G. Koniaris, and R.A. Mooney. 2003. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes. http://dx.doi.org/10.2337/diabetes.52.11.2784 52:2784-2789
68. Könner, A.C., and J.C. Brüning. 2011. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol. Metab. http://dx.doi.org/10.1016/j.tem.2010.08.007 22:16-23
69. Kosteli, A., E. Sugaru, G. Haemmerle, J.F. Martin, J. Lei, R. Zechner, and A.W. Ferrante Jr. 2010. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. http://dx.doi.org/10.1172/JCI42845 120:3466-3479
70. Lacey, D.C., A. Achuthan, A.J. Fleetwood, H. Dinh, J. Roiniotis, G.M. Scholz, M.W. Chang, S.K. Beckman, A.D. Cook, and J.A. Hamilton. 2012. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. http://dx.doi.org/10.4049/jimmunol.1103426 188:5752-5765
71. Lafontan, M., and D. Langin. 2009. Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid Res. http://dx.doi.org/10.1016/j.plipres.2009.05.001 48:275-297
72. Lagathu, C., L. Yvan-Charvet, J.P. Bastard, M. Maachi, A. Quignard-Boulangé, J. Capeau, and M. Caron. 2006. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia. http://dx.doi.org/10.1007/s00125-006-0335-z 49:2162-2173
73. Landin, K., P. Lönnroth, M. Krotkiewski, G. Holm, and U. Smith. 1990. Increased insulin resistance and fat cell lipolysis in obese but not lean women with a high waist/hip ratio. Eur. J. Clin. Invest. http://dx.doi.org/10.1111/j.1365-2362.1990.tb01922.x 20:530-535
74. Lin, S.C., Y.C. Lo, and H. Wu. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature. http://dx.doi.org/10.1038/nature09121 465:885-890
75. Lumeng, C.N., J.L. Bodzin, and A.R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. http://dx.doi.org/10.1172/JCI29881 117:175-184
76. Lundberg, A.M., D.F. Ketelhuth, M.E. Johansson, N. Gerdes, S. Liu, M. Yamamoto, S. Akira, and G.K. Hansson. 2013. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. Cardiovasc. Res. http://dx.doi.org/10.1093/cvr/cvt033 99:364-373
77. McCullough, A.J. 2011. Epidemiology of the metabolic syndrome in the USA. J. Dig. Dis. http://dx.doi.org/10.1111/j.1751-2980.2010.00469.x 12:333-340
78. Michelsen, K.S., M.H. Wong, P.K. Shah, W. Zhang, J. Yano, T.M. Doherty, S. Akira, T.B. Rajavashisth, and M. Arditi. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA. http://dx.doi.org/10.1073/pnas.0403249101 101:10679-10684
79. Miyazaki, T., J. Kurokawa, and S. Arai. 2011. AIMing at metabolic syndrome. -Towards the development of novel therapies for metabolic diseases via apoptosis inhibitor of macrophage (AIM).- Circ. J. http://dx.doi.org/10.1253/circj. CJ-11-0891 75:2522-2531
80. Monteiro, R., and I. Azevedo. 2010. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. http://dx.doi.org/10.1155/2010/289645 2010:2010
81. Morris, D.L., K.E. Oatmen, T. Wang, J.L. DelProposto, and C.N. Lumeng. 2012. CX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity. Obesity (Silver Spring). http://dx.doi.org/10.1038/oby.2012.7 20:1189-1199
82. Nagy, L., P. Tontonoz, J.G. Alvarez, H. Chen, and R.M. Evans. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. http://dx.doi.org/10.1016/S0092-8674(00)81574-3 93:229-240
83. Neels, J.G., and J.M. Olefsky. 2006. Inflamed fat: what starts the fire? J. Clin. Invest. http://dx.doi.org/10.1172/JCI27280 116:33-35
84. Nguyen, M.T., S. Favelyukis, A.K. Nguyen, D. Reichart, P.A. Scott, A. Jenn, R. Liu-Bryan, C.K. Glass, J.G. Neels, and J.M. Olefsky. 2007. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNKdependent pathways. J. Biol. Chem. http://dx.doi.org/10.1074/jbc. M706762200 282:35279-35292
85. Nishimura, S., I. Manabe, and R. Nagai. 2009. Adipose tissue inflammation in obesity and metabolic syndrome. Discov. Med. 8:55-60
86. Ohashi, K., J.L. Parker, N. Ouchi, A. Higuchi, J.A. Vita, N. Gokce, A.A. Pedersen, C. Kalthoff, S. Tullin, A. Sams, et al. 2010. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J. Biol. Chem. http://dx.doi.org/10.1074/jbc. M109.088708 285:6153-6160
87. Petrasek, J., A. Dolganiuc, T. Csak, B. Nath, I. Hritz, K. Kodys, D. Catalano, E. Kurt-Jones, P. Mandrekar, and G. Szabo. 2011. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology. http://dx.doi.org/10.1002/hep.24059 53:649-660
88. Plomgaard, P., K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J.R. Zierath, and B.K. Pedersen. 2005. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes. http://dx.doi.org/10.2337/diabetes.54.10.2939 54:2939-2945
89. Podrez, E.A., M. Febbraio, N. Sheibani, D. Schmitt, R.L. Silverstein, D.P. Hajjar, P.A. Cohen, W.A. Frazier, H.F. Hoff, and S.L. Hazen. 2000. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. http://dx.doi.org/10.1172/JCI8574 105:1095-1108
90. Prieur, X., C.Y. Mok, V.R. Velagapudi, V. Núñez, L. Fuentes, D. Montaner, K. Ishikawa, A. Camacho, N. Barbarroja, S. O'Rahilly, et al. 2011. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. http://dx.doi.org/10.2337/db10-0705 60:797-809
91. Richards, M.R., A.S. Black, D.J. Bonnet, G.D. Barish, C.W. Woo, I. Tabas, L.K. Curtiss, and P.S. Tobias. 2013. The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice. Innate Immun. http://dx.doi.org/10.1177/1753425912447130 19:20-29
92. Rios, F.J., M.M. Koga, M. Ferracini, and S. Jancar. 2012. Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation. PLoS ONE. http://dx.doi.org/10.1371/journal.pone.0036632 7:e36632
93. Rotter, V., I. Nagaev, and U. Smith. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. http://dx.doi.org/10.1074/jbc. M301977200 278:45777-45784
94. Seimon, T.A., M.J. Nadolski, X. Liao, J. Magallon, M. Nguyen, N.T. Feric, M.L. Koschinsky, R. Harkewicz, J.L. Witztum, S. Tsimikas, et al. 2010. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab. http://dx.doi.org/10.1016/j.cmet.2010.09.010 12:467-482
95. Shaposhnik, Z., X. Wang, M. Weinstein, B.J. Bennett, and A.J. Lusis. 2007. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. http://dx.doi.org/10.1161/01.ATV.0000254673.55431.e6 27:621-627
96. Shaul, M.E., G. Bennett, K.J. Strissel, A.S. Greenberg, and M.S. Obin. 2010. Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes. http://dx.doi.org/10.2337/db09-1402 59:1171-1181
97. Shi W., M.E. Haberland, M.L. Jien, D.M. Shih, and A.J. Lusis. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation. 2000. 102:75-81
98. Shi, H., M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. http://dx.doi.org/10.1172/JCI28898 116:3015-3025
99. Smith, D.D., X. Tan, O. Tawfik, G. Milne, D.J. Stechschulte, and K.N. Dileepan. 2010. Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production. J. Physiol. Pharmacol. 61:309-316
100. Staels, B. 2002. Cardiovascular biology: a cholesterol tether. Nature. http://dx.doi.org/10.1038/417699a 417:699-701
101. Stienstra, R., L.A. Joosten, T. Koenen, B. Van Tits, J.A. van Diepen, S.A. van den Berg, P.C. Rensen, P.J. Voshol, G. Fantuzzi, A. Hijmans, et al. 2010. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. http://dx.doi.org/10.1016/j.cmet.2010.11.011 12:593-605
102. Su, X., L. Ao, Y. Shi, T.R. Johnson, D.A. Fullerton, and X. Meng. 2011. Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4. J. Biol. Chem. http://dx.doi.org/10.1074/jbc. M110.214619 286:12213-12220
103. Subramanian, M., E. Thorp, G.K. Hansson, and I. Tabas. 2013. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. J. Clin. Invest. http://dx.doi.org/10.1172/JCI64617 123:179-188
104. Suganami, T., J. Nishida, and Y. Ogawa. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. http://dx.doi.org/10.1161/01.ATV.0000183883.72263.13 25: 2062-2068
105. Suganami, T., K. Tanimoto-Koyama, J. Nishida, M. Itoh, X. Yuan, S. Mizuarai, H. Kotani, S. Yamaoka, K. Miyake, S. Aoe, et al. 2007. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. http://dx.doi.org/10.1161/01.ATV.0000251608.09329.9a 27:84-91
106. Sun, K., C.M. Kusminski, and P.E. Scherer. 2011. Adipose tissue remodeling and obesity. J. Clin. Invest. http://dx.doi.org/10.1172/JCI45887 121:2094-2101
107. Takeuchi, O., and S. Akira. 2002. MyD88 as a bottle neck in Toll/IL-1 signaling. Curr. Top. Microbiol. Immunol. 270:155-167
108. Tordjman, K., C. Bernal-Mizrachi, L. Zemany, S. Weng, C. Feng, F. Zhang, T.C. Leone, T. Coleman, D.P. Kelly, and C.F. Semenkovich. 2001. PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. http://dx.doi.org/10.1172/JCI11497 107:1025-1034
109. Trujillo, M.E., S. Sullivan, I. Harten, S.H. Schneider, A.S. Greenberg, and S.K. Fried. 2004. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J. Clin. Endocrinol. Metab. http://dx.doi.org/10.1210/jc.2004-0603 89:5577-5582
110. Tsujita, T., C. Morimoto, and H. Okuda. 1995. Mechanism of increase in basal lipolysis of enlarged adipocytes in obese animals. Obes. Res. http://dx.doi.org/10.1002/j.1550-8528.1995.tb00478.x 3(Suppl 5): 633S-636S
111. van Tits, L.J., R. Stienstra, P.L. Van Lent, M.G. Netea, L.A. Joosten, and A.F. Stalenhoef. 2011. Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppellike factor 2. Atherosclerosis. http://dx.doi.org/10.1016/j.atherosclerosis.2010.11.018 214:345-349
112. Verreck, F.A., T. De Boer, D.M. Langenberg, M.A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T.H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA. http://dx.doi.org/10.1073/pnas.0400983101 101:4560-4565
113. Vita, J.A., M.L. Brennan, N. Gokce, S.A. Mann, M. Goormastic, M.H. Shishehbor, M.S. Penn, J.F. Keaney Jr., and S.L. Hazen. 2004. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. http://dx.doi.org/10.1161/01.CIR.0000140262.20831.8F 110:1134-1139
114. Wajchenberg, B.L., M. Nery, M.R. Cunha, and M.E. Silva. 2009. Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis. Arq. Bras. Endocrinol. Metabol. http://dx.doi.org/10.1590/S0004-27302009000200005 53:145-150
115. Waldo, S.W., Y. Li, C. Buono, B. Zhao, E.M. Billings, J. Chang, and H.S. Kruth. 2008. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol. http://dx.doi.org/10.2353/ajpath.2008.070513 172:1112-1126
116. Wärnberg, J., E. Nova, L.A. Moreno, J. Romeo, M.I. Mesana, J.R. Ruiz, F.B. Ortega, M. Sjöström, M. Bueno, and A. Marcos; AVENA Study Group. 2006. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am. J. Clin. Nutr. 84:505-512
117. Weisberg, S.P., D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. http://dx.doi.org/10.1172/JCI200319246 112:1796-1808
118. Wolfs, I.M., M.M. Donners, and M.P. de Winther. 2011. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Thromb. Haemost. http://dx.doi.org/10.1160/TH11-05-0320 106:763-771
119. Xu, H., G.T. Barnes, Q. Yang, G. Tan, D. Yang, C.J. Chou, J. Sole, A. Nichols, J.S. Ross, L.A. Tartaglia, and H. Chen. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. http://dx.doi.org/10.1172/JCI200319451 112:1821-1830
120. Yao, J., T.W. Kim, J. Qin, Z. Jiang, Y. Qian, H. Xiao, Y. Lu, W. Qian, M.F. Gulen, N. Sizemore, et al. 2007. Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modification. J. Biol. Chem. http://dx.doi.org/10.1074/jbc. M609039200 282:6075-6089
121. Zeyda, M., and T.M. Stulnig. 2007. Adipose tissue macrophages. Immunol. Lett. http://dx.doi.org/10.1016/j.imlet.2007.07.003 112:61-67
122. Zeyda, M., K. Gollinger, E. Kriehuber, F.W. Kiefer, A. Neuhofer, and T.M. Stulnig. 2010. Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression. Int J Obes (Lond). http://dx.doi.org/10.1038/ijo.2010.103 34:1684-1694
123. Zhang, R., M.L. Brennan, X. Fu, R.J. Aviles, G.L. Pearce, M.S. Penn, E.J. Topol, D.L. Sprecher, and S.L. Hazen. 2001. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. http://dx.doi.org/10.1001/jama.286.17.2136 286:2136-2142
124. Zhu, S.N., M. Chen, J. Jongstra-Bilen, and M.I. Cybulsky. 2009. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. http://dx.doi.org/10.1084/jem.20090866 206:2141-2149
125. Zieske, A.W., R.P. Tracy, C.A. McMahan, E.E. Herderick, S. Homma, G.T. Malcom, H.C. McGill Jr., and J.P. Strong; Pathobiological Determinants of Atherosclerosis in Youth Research Group. 2005. Elevated serum Creactive protein levels and advanced atherosclerosis in youth. Arterioscler. Thromb. Vasc. Biol. http://dx.doi.org/10.1161/01.ATV.0000164625.93129.64 25:1237-1243